Study: Merck hep C combo effective in kidney disease patients

Study: Merck hep C combo effective in kidney disease patients Earlier this year, the FDA granted Merck breakthrough status for its combined grazoprevir/elbasvir combination medication for treatment of hepattis C (HCV). Merck is also targeting patients with severe kidney impairment … Continue reading